Elicio Therapeutics Grants 30,300 Inducement Stock Options to New Employee
Elicio Therapeutics announced that on February 17, 2026, Elicio granted an aggregate of 30,300 inducement stock options to a new employee, as an inducement material to such individual entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock options were approved by the Compensation Committee of Elicio's Board of Directors and granted under the Elicio Therapeutics, Inc. 2024 Inducement Incentive Award Plan. The grant provides for the purchase of shares of Elicio common stock at a price of $8.59 per share, the closing price per share of Elicio common stock as reported by Nasdaq on February 17, 2026, the date of grant. The grant vests over four years, with 25 percent of the shares vesting on the first anniversary of the employee's start date, and the remainder vesting ratably at the end of each subsequent month thereafter, subject to such employee's continued service relationship with Elicio through the applicable vesting dates.
